Prognostic value and susceptibility of BAX rs4645878 polymorphism in cancer: A systematic review and meta-analysis

Medicine
Ye FengShao-Yuan Wang

Abstract

BCL-2 Associated X (BAX) is an important modulator of apoptosis. The associations between BAX gene polymorphism and cancer susceptibility and prognosis in different ethnic groups and types of cancer have yielded controversial results. To reconcile the results, a systematic review followed by meta-analysis was performed to assess the associations. A systematic search of Medline database (PubMed), EMBASE, China Biology Medicine disc, China National Knowledge Infrastructure, Wanfang databases for publications on BAX polymorphisms, and susceptibility and prognosis was carried out until July 2017. Retrieved 14 articles met the inclusions. Summary odds ratios (ORs) and hazard ratios (HRs) with their 95% confidence intervals (CIs) were harnessed to determine the strength of correlation between BAX polymorphisms and cancer susceptibility and prognosis, which were combined using fixed- or random-effects models as appropriate. A total of 12 trials involving 3321 cases and 3209 controls were included in our pooled analysis regarding the polymorphisms and the susceptibility of cancers. Overall, results of the present meta-analysis demonstrated that there was no significant association between BAX polymorphisms and susceptibility of cancers...Continue Reading

References

Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Nov 14, 2000·The American Journal of Pathology·J C Reed
Oct 16, 2001·Nature Genetics·J P IoannidisD G Contopoulos-Ioannidis
Aug 15, 2002·The Journal of Surgical Research·Elissa C PirocanacMichael Bouvet
May 16, 2003·American Journal of Hematology·Sang Kyun SohnKyu Bo Lee
Mar 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jane StarczynskiChristopher Fegan
Sep 17, 2005·Proceedings of the National Academy of Sciences of the United States of America·Amelia CimminoCarlo M Croce
Feb 18, 2010·Molecular Cell·Jerry E ChipukDouglas R Green
Jan 28, 2014·Journal of Dermatological Science·Cristiane OliveiraCarmen Silvia Passos Lima
Sep 18, 2014·Nature Communications·Meiguo XinXingming Deng
May 11, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Anuradha CingeethamVishnupriya Satti
Jul 26, 2015·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·S DholariyaP C Ray
Sep 24, 2015·Medicinal Research Reviews·Zhiqing LiuJia Zhou
Apr 22, 2016·British Journal of Haematology·Angelo B C BritoCarmen Silvia Passos Lima
Jul 21, 2017·Blood·Matthew S Davids

❮ Previous
Next ❯

Citations

Feb 1, 2019·Apoptosis : an International Journal on Programmed Cell Death·Abbas Mohammadpour-GharehbaghSaeedeh Salimi
Jun 28, 2019·Journal of Cellular Biochemistry·Mohammad Reza KalhoriFatemeh Kouhkan
Apr 3, 2019·Journal of Assisted Reproduction and Genetics·Rafael Tomoya MichitaPriscila Vianna

❮ Previous
Next ❯

Software Mentioned

Engauge Digitizer
STATA

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.